tiprankstipranks
UroGen Pharma Announces CFO Transition and Compensation Details
PremiumCompany AnnouncementsUroGen Pharma Announces CFO Transition and Compensation Details
1M ago
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
Premium
The Fly
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
1M ago
UroGen Pharma: Patient dosed in mitomycin-based UGN-103 trial for LG-IR-NMIBC
Premium
The Fly
UroGen Pharma: Patient dosed in mitomycin-based UGN-103 trial for LG-IR-NMIBC
2M ago
UroGen Pharma says ahead of schedule to complete UGN-102 NDA
PremiumThe FlyUroGen Pharma says ahead of schedule to complete UGN-102 NDA
3M ago
UroGen Pharma reports Q2 EPS (91c), consensus (83c)
Premium
The Fly
UroGen Pharma reports Q2 EPS (91c), consensus (83c)
3M ago
Is URGN a Buy, Before Earnings?
Premium
Pre-Earnings
Is URGN a Buy, Before Earnings?
3M ago
UroGen Pharma price target raised to $40 from $32 at Oppenheimer
PremiumThe FlyUroGen Pharma price target raised to $40 from $32 at Oppenheimer
5M ago
UroGen Pharma price target raised to $53.50 from $48 at Ladenburg
Premium
The Fly
UroGen Pharma price target raised to $53.50 from $48 at Ladenburg
5M ago
UroGen Pharma price target raised to $60 from $54 at H.C. Wainwright
Premium
The Fly
UroGen Pharma price target raised to $60 from $54 at H.C. Wainwright
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100